Expression of hepatocyte growth factor/c-met by RT-PCR in meningiomas

Na Rae Kim, Yang Seok Chae, Weon Jeong Lim, Seong Jin Cho

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Hepatocyte growth factor (HGF) is a potent mitogenic cytokine. C-met protein, which is known to be the HGF receptor has transmembrane tyrosine kinase activity and is encoded by the c-met oncogene. The HGF/c-met signaling pathway may play various roles in the carcinogenesis of various organs. Methods: We examined HGF and c-met mRNA expression by utilizing reverse transcription polymerase chain reaction on 40 surgically resected intracranial meningiomas (25 benign, 10 atypical, and 5 anaplastic cases). Results: An HGF overexpression was detected in 28%, 50%, and 80% of the benign, atypical and anaplastic meningiomas, respectively; a high expression of HGF or the coexpression of HGF/c-met was detected in the high grade meningiomas (the atypical and anaplastic cases, p=0.046, p=0.014). An HGF expression was statistically significant in the recurrent meningiomas (p=0.003), and HGF expression was significantly lower than c-met mRNA expression in benign meningiomas (p=0.034). Conclusions: There was no correlation between histologic subtypes and HGF/c-met expression. Determination of HGF expression can be used as a molecular predictor for recurrence of meningioimas. These results suggest that HGF and c-met expression in meningiomas may be associated with anaplastic progression.

Original languageEnglish
Pages (from-to)463-468
Number of pages6
JournalKorean Journal of Pathology
Volume45
Issue number5
DOIs
Publication statusPublished - 2011 Oct 1

Fingerprint

Hepatocyte Growth Factor
Meningioma
Polymerase Chain Reaction
Proto-Oncogene Proteins c-met
Messenger RNA
Protein C
Oncogenes
Protein-Tyrosine Kinases
Reverse Transcription
Carcinogenesis
Cytokines

Keywords

  • C-met
  • Hepatocyte growth factor
  • Meningioma
  • Neoplasm recurrence, local
  • Reverse transcription polymerase chain reaction

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Expression of hepatocyte growth factor/c-met by RT-PCR in meningiomas. / Kim, Na Rae; Chae, Yang Seok; Lim, Weon Jeong; Cho, Seong Jin.

In: Korean Journal of Pathology, Vol. 45, No. 5, 01.10.2011, p. 463-468.

Research output: Contribution to journalArticle

Kim, Na Rae ; Chae, Yang Seok ; Lim, Weon Jeong ; Cho, Seong Jin. / Expression of hepatocyte growth factor/c-met by RT-PCR in meningiomas. In: Korean Journal of Pathology. 2011 ; Vol. 45, No. 5. pp. 463-468.
@article{f0064a38ee6a4c629aacfe8001447e76,
title = "Expression of hepatocyte growth factor/c-met by RT-PCR in meningiomas",
abstract = "Background: Hepatocyte growth factor (HGF) is a potent mitogenic cytokine. C-met protein, which is known to be the HGF receptor has transmembrane tyrosine kinase activity and is encoded by the c-met oncogene. The HGF/c-met signaling pathway may play various roles in the carcinogenesis of various organs. Methods: We examined HGF and c-met mRNA expression by utilizing reverse transcription polymerase chain reaction on 40 surgically resected intracranial meningiomas (25 benign, 10 atypical, and 5 anaplastic cases). Results: An HGF overexpression was detected in 28{\%}, 50{\%}, and 80{\%} of the benign, atypical and anaplastic meningiomas, respectively; a high expression of HGF or the coexpression of HGF/c-met was detected in the high grade meningiomas (the atypical and anaplastic cases, p=0.046, p=0.014). An HGF expression was statistically significant in the recurrent meningiomas (p=0.003), and HGF expression was significantly lower than c-met mRNA expression in benign meningiomas (p=0.034). Conclusions: There was no correlation between histologic subtypes and HGF/c-met expression. Determination of HGF expression can be used as a molecular predictor for recurrence of meningioimas. These results suggest that HGF and c-met expression in meningiomas may be associated with anaplastic progression.",
keywords = "C-met, Hepatocyte growth factor, Meningioma, Neoplasm recurrence, local, Reverse transcription polymerase chain reaction",
author = "Kim, {Na Rae} and Chae, {Yang Seok} and Lim, {Weon Jeong} and Cho, {Seong Jin}",
year = "2011",
month = "10",
day = "1",
doi = "10.4132/KoreanJPathol.2011.45.5.537",
language = "English",
volume = "45",
pages = "463--468",
journal = "Journal of Pathology and Translational Medicine",
issn = "2383-7837",
publisher = "Korean Society of Pathologists",
number = "5",

}

TY - JOUR

T1 - Expression of hepatocyte growth factor/c-met by RT-PCR in meningiomas

AU - Kim, Na Rae

AU - Chae, Yang Seok

AU - Lim, Weon Jeong

AU - Cho, Seong Jin

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Background: Hepatocyte growth factor (HGF) is a potent mitogenic cytokine. C-met protein, which is known to be the HGF receptor has transmembrane tyrosine kinase activity and is encoded by the c-met oncogene. The HGF/c-met signaling pathway may play various roles in the carcinogenesis of various organs. Methods: We examined HGF and c-met mRNA expression by utilizing reverse transcription polymerase chain reaction on 40 surgically resected intracranial meningiomas (25 benign, 10 atypical, and 5 anaplastic cases). Results: An HGF overexpression was detected in 28%, 50%, and 80% of the benign, atypical and anaplastic meningiomas, respectively; a high expression of HGF or the coexpression of HGF/c-met was detected in the high grade meningiomas (the atypical and anaplastic cases, p=0.046, p=0.014). An HGF expression was statistically significant in the recurrent meningiomas (p=0.003), and HGF expression was significantly lower than c-met mRNA expression in benign meningiomas (p=0.034). Conclusions: There was no correlation between histologic subtypes and HGF/c-met expression. Determination of HGF expression can be used as a molecular predictor for recurrence of meningioimas. These results suggest that HGF and c-met expression in meningiomas may be associated with anaplastic progression.

AB - Background: Hepatocyte growth factor (HGF) is a potent mitogenic cytokine. C-met protein, which is known to be the HGF receptor has transmembrane tyrosine kinase activity and is encoded by the c-met oncogene. The HGF/c-met signaling pathway may play various roles in the carcinogenesis of various organs. Methods: We examined HGF and c-met mRNA expression by utilizing reverse transcription polymerase chain reaction on 40 surgically resected intracranial meningiomas (25 benign, 10 atypical, and 5 anaplastic cases). Results: An HGF overexpression was detected in 28%, 50%, and 80% of the benign, atypical and anaplastic meningiomas, respectively; a high expression of HGF or the coexpression of HGF/c-met was detected in the high grade meningiomas (the atypical and anaplastic cases, p=0.046, p=0.014). An HGF expression was statistically significant in the recurrent meningiomas (p=0.003), and HGF expression was significantly lower than c-met mRNA expression in benign meningiomas (p=0.034). Conclusions: There was no correlation between histologic subtypes and HGF/c-met expression. Determination of HGF expression can be used as a molecular predictor for recurrence of meningioimas. These results suggest that HGF and c-met expression in meningiomas may be associated with anaplastic progression.

KW - C-met

KW - Hepatocyte growth factor

KW - Meningioma

KW - Neoplasm recurrence, local

KW - Reverse transcription polymerase chain reaction

UR - http://www.scopus.com/inward/record.url?scp=84856655644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856655644&partnerID=8YFLogxK

U2 - 10.4132/KoreanJPathol.2011.45.5.537

DO - 10.4132/KoreanJPathol.2011.45.5.537

M3 - Article

VL - 45

SP - 463

EP - 468

JO - Journal of Pathology and Translational Medicine

JF - Journal of Pathology and Translational Medicine

SN - 2383-7837

IS - 5

ER -